Fundies. English
NANOVIRICIDES, INC.
EDGAR110 filing records in this dataset, filed from 2007-02-15 to 2026-09-28. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 2.8 million Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA Source
Exact value
2800000 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 23 million Unit_Standard_shares_oaC8LpVIskCwAsdVOpaR5Q Source
Exact value
23008308 Unit_Standard_shares_oaC8LpVIskCwAsdVOpaR5Q
Reported share-count change
38.55% · 6.4 million Unit_Standard_shares_oaC8LpVIskCwAsdVOpaR5Q
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-09-28.
Financial data available through: 2026-06-30.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 2 of 11 periods available· newest 2026-06-30
- Net income: 2 of 11 periods available· newest 2026-06-30
- Operating cash flow: 2 of 11 periods available· newest 2026-06-30
- Capital expenditure: 2 of 11 periods available· newest 2026-06-30
- Total assets: 2 of 11 periods available· newest 2026-06-30
- Total liabilities: 1 of 11 periods available· newest 2026-06-30
- Current assets: 2 of 11 periods available· newest 2026-06-30
- Current liabilities: 2 of 11 periods available· newest 2026-06-30
- Cash and cash equivalents: 2 of 11 periods available· newest 2026-06-30
- long term debt: No compatible figures in this window
- Shares outstanding: 2 of 11 periods available· newest 2026-06-30
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 1.27 millionPrior period
−Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 9.47 million
–
Current period
−Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 8.2 million
–
Exact inputs and evidence
-8200000 − -9466966 = 1266966 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA
-9466966 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA · 2024-07-01 – 2025-06-30
Inspect prior input Prior source-8200000 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA · 2025-07-01 – 2026-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 778,679Prior period
−Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 8.48 million
–
Current period
−Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 7.7 million
–
Exact inputs and evidence
-7700000 − -8478679 = 778679 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA
-8478679 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA · 2024-07-01 – 2025-06-30
Inspect prior input Prior source-7700000 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA · 2025-07-01 – 2026-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+48%Prior period
Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 56,964
–
Current period
Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 84,317
–
Exact inputs and evidence
84317 − 56964 = 27353 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA
56964 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA · 2024-07-01 – 2025-06-30
Inspect prior input Prior source84317 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA · 2025-07-01 – 2026-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2025 2024-07-01 – 2025-06-30 | −Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 9.47 million Exact valueExact value: -9466966 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 2024-07-01 – 2025-06-30: -9466966 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 8.48 million Exact valueExact value: -8478679 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 2024-07-01 – 2025-06-30: -8478679 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 56,964 Exact valueExact value: 56964 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 2024-07-01 – 2025-06-30: 56964 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA Inspect Capital Expenditure Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 8.54 million Calculation and evidence-8478679 − 56964 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA Exact free cash flow: -8535643 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-07-01 – 2026-06-30 | −Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 8.2 million Exact valueExact value: -8200000 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 2025-07-01 – 2026-06-30: -8200000 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 7.7 million Exact valueExact value: -7700000 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 2025-07-01 – 2026-06-30: -7700000 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 84,317 Exact valueExact value: 84317 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 2025-07-01 – 2026-06-30: 84317 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA Inspect Capital Expenditure Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA 7.78 million Calculation and evidence-7700000 − 84317 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA Exact free cash flow: -7784317 Unit_Standard_USD_QRJ7HZxl-UKhh7t0PU8ALA
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
110 filings · 4,530 latest values · 4,530 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001379006, 1379006, NNVC, edgar:1379006, nnvc
Also known as NANOVIRICIDES, INC., NANOVIRICIDES, INC.